Cinctive Capital Management LP Esperion Therapeutics, Inc. Transaction History

Cinctive Capital Management LP

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$4.81 - $11.92 $531,783 - $1.32 Million	-110,558 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$11.34 - $21.37 $857,440 - $1.62 Million	-75,612 Reduced 40.61%	110,558 $1.33 Million
Q2 2021 Aug 16, 2021	BUY	$19.4 - $28.71 $265,915 - $393,527	13,707 Added 7.95%	186,170 $3.94 Million
Q1 2021 May 17, 2021	SELL	$25.12 - $36.89 $285,388 - $419,107	-11,361 Reduced 6.18%	172,463 $4.84 Million
Q4 2020 Feb 16, 2021	BUY	$24.2 - $35.76 $1.01 Million - $1.49 Million	41,560 Added 29.21%	183,824 $4.78 Million
Q3 2020 Nov 16, 2020	BUY	$31.18 - $52.71 $1.48 Million - $2.5 Million	47,357 Added 49.9%	142,264 $5.29 Million
Q2 2020 Aug 14, 2020	BUY	$30.04 - $51.31 $2.21 Million - $3.77 Million	73,556 Added 344.51%	94,907 $4.87 Million
Q1 2020 May 15, 2020	BUY	$27.44 - $73.84 $585,871 - $1.58 Million	21,351 New	21,351 $673,000

206

128M

1.67M

930K

Ticker ESPR
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 66,551,600
Market Cap $153M
Description
Esperion Therapeutics, Inc., a pharmaceutical company, develops and commercializes medicines for the treatment of patients with elevated low density lipoprotein cholesterol. Its lead product candidates are NEXLETOL (bempedoic acid) and NEXLIZET (bempedoic acid and ezetimibe) tablets for the treatment of patients with atherosclerotic cardiovascul...

Get notified when there are updates to the investment portfolio of Cinctive Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Cinctive Capital Management LP with notifications on news.